Yu‐I Weng

542 total citations
10 papers, 445 citations indexed

About

Yu‐I Weng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Complementary and alternative medicine. According to data from OpenAlex, Yu‐I Weng has authored 10 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Cardiology and Cardiovascular Medicine and 2 papers in Complementary and alternative medicine. Recurrent topics in Yu‐I Weng's work include Epigenetics and DNA Methylation (4 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and RNA modifications and cancer (2 papers). Yu‐I Weng is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and RNA modifications and cancer (2 papers). Yu‐I Weng collaborates with scholars based in United States, Taiwan and Hong Kong. Yu‐I Weng's co-authors include Shivendra D. Shukla, Yuan‐Teh Lee, Gary A. Weisman, Brent W. Krugh, Jianfeng Xu, Grace Y. Sun, Zhongji Liao, Yi‐Wen Huang, Tim H.‐M. Huang and Ming‐Chih Lee and has published in prestigious journals such as Cancer Research, Journal of Neurochemistry and British Journal of Pharmacology.

In The Last Decade

Yu‐I Weng

10 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐I Weng United States 9 262 54 49 47 45 10 445
Rachana Thapliyal India 7 348 1.3× 68 1.3× 32 0.7× 20 0.4× 31 0.7× 9 602
Da-Hye Lee South Korea 14 221 0.8× 57 1.1× 50 1.0× 34 0.7× 36 0.8× 22 493
Ah Ng Tony Kong United States 7 190 0.7× 30 0.6× 77 1.6× 31 0.7× 30 0.7× 9 359
Sarandeep S. S. Boyanapalli United States 11 450 1.7× 48 0.9× 64 1.3× 35 0.7× 30 0.7× 11 630
Hyun-Ock Pae South Korea 8 210 0.8× 82 1.5× 41 0.8× 26 0.6× 22 0.5× 9 432
Young Eun Jeon South Korea 15 217 0.8× 63 1.2× 33 0.7× 22 0.5× 41 0.9× 36 584
Atef N. Hanna United States 14 221 0.8× 57 1.1× 36 0.7× 62 1.3× 28 0.6× 24 566
Theodore R. Witte United States 9 205 0.8× 56 1.0× 107 2.2× 33 0.7× 25 0.6× 12 472

Countries citing papers authored by Yu‐I Weng

Since Specialization
Citations

This map shows the geographic impact of Yu‐I Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐I Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐I Weng more than expected).

Fields of papers citing papers by Yu‐I Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐I Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐I Weng. The network helps show where Yu‐I Weng may publish in the future.

Co-authorship network of co-authors of Yu‐I Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐I Weng. A scholar is included among the top collaborators of Yu‐I Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐I Weng. Yu‐I Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Weng, Yu‐I, et al.. (2020). Detection of DNA Methylation by MeDIP and MBDCap Assays: An Overview of Techniques. Methods in molecular biology. 225–234. 10 indexed citations
2.
Wang, Li‐Shu, Chieh‐Ti Kuo, Claire Seguin, et al.. (2013). Black Raspberry-Derived Anthocyanins Demethylate Tumor Suppressor Genes Through the Inhibition of DNMT1 and DNMT3B in Colon Cancer Cells. Nutrition and Cancer. 65(1). 118–125. 103 indexed citations
3.
Lin, Hsiang‐Yu, Yu‐I Weng, I‐Lu Lai, et al.. (2012). Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction‐mimetic agent. The Prostate. 72(16). 1767–1778. 16 indexed citations
4.
Zuo, Tao, Xun Lan, Yu‐I Weng, et al.. (2011). Epigenetic Silencing Mediated through Activated PI3K/AKT Signaling in Breast Cancer. Cancer Research. 71(5). 1752–1762. 52 indexed citations
5.
Weng, Yu‐I & Shivendra D. Shukla. (2002). Angiotensin II activation of focal adhesion kinase and pp60c-Src in relation to mitogen-activated protein kinases in hepatocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1589(3). 285–297. 31 indexed citations
6.
Xu, Jianfeng, Yu‐I Weng, Brent W. Krugh, et al.. (2002). Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. Journal of Neurochemistry. 83(2). 259–270. 104 indexed citations
7.
Xu, Jianfeng, Yu‐I Weng, Ágnes Simonyi, et al.. (2002). Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes. Journal of Neurochemistry. 83(5). 1239–1239. 1 indexed citations
8.
Weng, Yu‐I & Shivendra D. Shukla. (2000). Ethanol alters angiotensin II stimulated mitogen activated protein kinase in hepatocytes: agonist selectivity and ethanol metabolic independence. European Journal of Pharmacology. 398(3). 323–331. 37 indexed citations
9.
Huang, Huei‐Chen, et al.. (1993). Protection by scoparone against the alterations of plasma lipoproteins, vascular morphology and vascular reactivity in hyperlipidaemic diabetic rabbit. British Journal of Pharmacology. 110(4). 1508–1514. 33 indexed citations
10.
Weng, Yu‐I, et al.. (1992). Vasodilator effect of scoparone (6,7-dimethoxycoumarin) from a Chinese herb. European Journal of Pharmacology. 218(1). 123–128. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachana Thapliyal Breakdown of academic impact, for papers by Da-Hye Lee Breakdown of academic impact, for papers by Ah Ng Tony Kong Breakdown of academic impact, for papers by Sarandeep S. S. Boyanapalli Breakdown of academic impact, for papers by Hyun-Ock Pae Breakdown of academic impact, for papers by Young Eun Jeon Breakdown of academic impact, for papers by Atef N. Hanna Breakdown of academic impact, for papers by Theodore R. Witte
Rankless by CCL
2026